Vega Investment Solutions Invests $1.14 Million in CVS Health Corporation $CVS

Posted by Brian Himes on Aug 25th, 2026

Vega Investment Solutions acquired a new stake in CVS Health Corporation (NYSE:CVS – Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The fund acquired 10,997 shares of the pharmacy operator’s stock, valued at approximately $1,138,000.

Several other institutional investors have also added to or reduced their stakes in CVS. Handelsbanken Fonder AB boosted its position in shares of CVS Health by 83.6% in the second quarter. Handelsbanken Fonder AB now owns 1,089,694 shares of the pharmacy operator’s stock valued at $112,729,000 after acquiring an additional 496,124 shares during the period. State Street Corp boosted its holdings in CVS Health by 2.1% in the 4th quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator’s stock valued at $4,776,182,000 after purchasing an additional 1,245,457 shares during the period. Legal & General Group Plc grew its position in shares of CVS Health by 0.3% during the 4th quarter. Legal & General Group Plc now owns 9,309,182 shares of the pharmacy operator’s stock valued at $738,777,000 after purchasing an additional 31,249 shares in the last quarter. Deutsche Bank AG increased its holdings in shares of CVS Health by 28.4% in the fourth quarter. Deutsche Bank AG now owns 4,666,495 shares of the pharmacy operator’s stock worth $370,333,000 after purchasing an additional 1,031,998 shares during the period. Finally, Oppenheimer Asset Management Inc. purchased a new stake in shares of CVS Health in the second quarter worth $49,622,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on CVS shares. UBS Group boosted their target price on CVS Health from $122.00 to $126.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. Piper Sandler reaffirmed an “overweight” rating and issued a $113.00 price target on shares of CVS Health in a report on Monday, June 1st. Wells Fargo & Company lifted their price target on CVS Health from $103.00 to $123.00 and gave the company an “overweight” rating in a research report on Monday, July 13th. Bank of America boosted their price objective on CVS Health from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Monday, June 22nd. Finally, Robert W. Baird set a $107.00 target price on shares of CVS Health in a research note on Thursday, August 6th. Twenty-two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $107.17.

Get Our Latest Stock Report on CVS Health

CVS Health Stock Up 1.1%

CVS opened at $94.06 on Tuesday. The business’s fifty day simple moving average is $101.88 and its 200 day simple moving average is $89.08. CVS Health Corporation has a 52 week low of $69.51 and a 52 week high of $110.68. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. The stock has a market cap of $120.31 billion, a PE ratio of 24.88, a P/E/G ratio of 0.85 and a beta of 0.61.

CVS Health (NYSE:CVS – Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.87 by $0.71. The firm had revenue of $106.10 billion during the quarter, compared to analyst estimates of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The company’s revenue was up 7.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, research analysts expect that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 annualized dividend and a yield of 2.8%. CVS Health’s dividend payout ratio is currently 70.37%.

CVS Health Company Profile

(Free Report)

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.